TCL Archive In Brief: NIDR, NCI award $2.8 Million In Grants For Oral Cancer research Centers October 4, 1996
TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012